DMEPOS Provider Information

DMEPOS Announcements

DMEPOS Temporary COVID-19 Guidelines

Alaska Medicaid has implemented temporary COVID-19 guidelines that effect DME and P&O providers. Access current DMEPOS temporary guidelines here. Providers may also review all Alaska Medicaid program announcements regarding COVID-19 on the Health Enterprise Home Page.

DME Quarterly Update Teleconference October 2020

Thank you to all of the providers that attended our quarterly DME teleconference! The October 2020 presentation is available under Quarterly Teleconference Presentations. Our next meeting is projected for January 13, 2021 at 10:00 a.m. AKST.

Alaska Medicaid DMEPOS FAQs

Click on a question to view the answer below it.

Enteral Pricing Research

Q: B4087 Gastro-Jejuno Tube, standard
A: No change in rate

Q: B4088 Gastro-Jejuno tube, low profile
A: There is no change for B4088 when item is dispensed individually. When the MicKey button is provided as a kit and with an approved service authorization, B4088 CG may be claimed for rate of $121.56 with a quantity of 1 every 3 months.

Q: B4100 Food thickener, oral per ounce
A: No change in rate

Q: B4150 Enteral nutritionally complete with intact nutrients
A: No change in rate

Q: B4154 Enteral nutritionally complete for special metabolic needs
A: No change in rate

Q: B4155 Enteral, nutritionally incomplete
A: This request has not been completed. Upon determination of criteria for authorization of MCT Procal Powder, the rate will be reviewed and request finalized.

Q: B4157 Enteral Nutrition Complete Special Metab Needs
A: This code is currently listed as ‘By Report’ requiring unaltered acquisition invoice submission with claims. Rate will be reviewed and determined in the coming months.

Q: B4158 Enteral for pediatrics nutritionally complete
A: No change in rate

Q: B4160 Enteral for pediatrics nutritionally complete, calorically dense
A: No change in rate

Q: B4161 Enteral for pediatrics, hydrolyzed-amino acids and peptide chain.
A: No change in rate

Q: T4541 Incontinence disposable underpad, large
A: No change in rate


Q: If we dispense a 90-day supply, will my claim auto-deny for excess quantity?
A: No. These claims are suspended and reviewed by the State for reimbursement.

Q: Do I have to submit documentation that the recipient agreed to a 90-day supply?
A: No. However, this documentation should be on file with provider.

Q: Do I have to submit documentation that the recipient agreed to a 90-day supply?
A: No. However, this documentation should be on file with provider.

Q: I have some enteral SAs that are expiring in between the timeframes listed on the temporary guidelines, what do I do?
A: Follow the directions within the DMEPOS Temporary Guidelines During COVID-19 Outbreak. If you still have specific concerns, email the State for individual assistance on those SAs.

Q: Are all RAD devices, including CPAPs and BiPAPs, included in the ventilator and oxygen section of the guidelines?
A: No. Due to the extensive qualification requirements, we are developing additional guidelines specific to these devices.

Q: Will Alaska Medicaid allow a new wheelchair evaluation to be performed through telemedicine?
A: Not at this time. We are reviewing this area of the program and will provide further guidance as applicable.

Quarterly Teleconference Presentations

October 21, 2020
July 9, 2020
April 8, 2020
January 8, 2020